Evaluating a tailored physical activity program for children with juvenile idiopathic arthritis
Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study
This study is testing a special exercise program for kids with juvenile idiopathic arthritis to see if it helps them move better and feel less pain.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 6 Years to 17 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Besancon Academic / other |
| Locations | 3 sites (Besançon and 2 other locations) |
| Trial ID | NCT05572424 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility and efficacy of an Adapted Physical Activity (APA) program for children aged 6 to 17 with juvenile idiopathic arthritis (JIA). Participants will engage in tailored physical activities while using a pedometer watch to monitor their activity levels. The goal is to assess how this program impacts disease activity and overall mobility in young patients suffering from JIA. The study aims to provide insights into effective rehabilitation methods for this population.
Who should consider this trial
Good fit: Ideal candidates are children aged 6 to 17 years diagnosed with juvenile idiopathic arthritis who have been stable on treatment for at least three months.
Not a fit: Patients with less than one year of disease progression or those not affiliated with a French social security system may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could improve physical activity levels and reduce disease activity in children with juvenile idiopathic arthritis.
How similar studies have performed: While there is growing interest in adapted physical activities for JIA, this specific approach is relatively novel and requires further investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Children (boys and girls) aged 6 to 17 years * Children with juvenile idiopathic arthritis (JIA) : oligoarticular, polyarticular, psoriatic or enthesitis-related arthritis, with more than one year of disease progression * Children on stable conventional or biotherapy 3 months prior to inclusion * Children with a computer/tablet/connected phone that allows them to follow adapted physical activities sessions online * If sexually active adolescents, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double barrier method, contraceptive patches) * Signed informed consent to participate indicating that the parent(s) understand the purpose and procedures required for the study and agree(s) that their child(ren) will participate in the study and abide by the requirements and restrictions of the study * Affiliation with a French social security system or beneficiary of such a system. Non-inclusion criteria: * Treatment by intra-articular infiltration less than 1 month old (immobilization required after the procedure and temporary cessation of physical activity unavoidable) * Contraindications to physical activity * Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator * Subject without health insurance * Pregnant adolescent * Subject in the exclusion period of another study or is the "national volunteer register" Exclusion criteria : * Intra-articular infiltration treatment during the 3 months of the adapted physical activity (APA) program (except for the temporomandibular joint) * Change of biotherapy during the 3 months of the APA program if the treatment is ineffective * Physical inability to engage in physical activity, unrelated to JIA, during the 3-month of the APA program
Where this trial is running
Besançon and 2 other locations
- CHU de Besançon — Besançon, France (Recruiting)
- Hospices Civils de Lyon — Lyon, France (Recruiting)
- Hôpital Nord Franche-Comté — Trévenans, France (Recruiting)
Study contacts
- Principal investigator: Claire BALLOT-SCHMIT, MD — CHU de Besançon
- Study coordinator: Claire BALLOT-SCHMIT, MD
- Email: cballotschmit@chu-besancon.fr
- Phone: 0381219139
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.